• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
MEDS

MEDS

TRxADE HEALTH, Inc.

NASDAQHealthcareMedical - PharmaceuticalsUS

USD7.59

+0.33 (+4.55%)

Company Profile

CEO

Surendra K. Ajjarapu

IPO Date

2014-02-06

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Exchange

NASDAQ

Country

US

Market Metrics

Open

$7.25

Prev. Close

$7.26

Day Low

$7.06

Day High

$7.70

52W Low

$3.69

52W High

$44.56

Market Cap

$0.01B

Volume

0.02M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

59.8%

Avg Negative

12.1%

Avg Neutral

28.0%

News Feed

TRxADE HEALTH, Inc. (MEDS) CEO Suren Ajjarapu on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·7/26/2021·↓ negative

Recap: Trxade Health Q2 Earnings

Benzinga·7/26/2021·↓ negative

MEDS Stock Increased Over 50% Intraday: Why It Happened

Pulse2·7/21/2021·↑ positive

MEDS Stock: 6 Things to Know About Trxade Health as Shares Rocket Higher Today

InvestorPlace·7/21/2021·↑ positive

Why TRxADE Health Shares Are Skyrocketing Today

Benzinga·7/21/2021·↑ positive

Winn-Dixie (Southeastern Grocers, Inc.) and Bonum Health(TM) (TRxADE HEALTH Company) Ink Telemedicine Deal

Accesswire·7/21/2021·↑ positive

TRxADE HEALTH to Report Second Quarter 2021 Financial Results on Monday, July 26th at 4:30 p.m. Eastern Time

Accesswire·7/12/2021·↑ positive

Why TRxADE HEALTH Shares Surged On Thursday

Benzinga·7/1/2021·↑ positive

MEDS Stock: The Big Bonum Health Deal That Has TRxADE Health Soaring Today

InvestorPlace·7/1/2021·↑ positive

MEDS Stock Price Increases Over 115%: Why It Happened

Pulse2·7/1/2021·↑ positive